Hepatic metastases from neuroendocrine tumors with a "thin slice" pathological examination: they are many more than you think.
- PMID: 20010089
- DOI: 10.1097/SLA.0b013e3181bdf8cf
Hepatic metastases from neuroendocrine tumors with a "thin slice" pathological examination: they are many more than you think.
Abstract
Objectives: To prospectively compare the results of the pathologic examination including thin 3- to 4-mm thick serial slices of the surgical specimen in a well-defined anatomic part of the liver with those of 4 different liver imaging techniques. BACKGROUNDS SUMMARY DATA: Liver metastases (LM) of neuroendocrine origin are frequent and accuracy of pretherapeutic liver imaging in detecting small-sized LM is questioned, but no study has compared the different techniques used to image large liver specimens and meticulous pathologic examination.
Patients and methods: Eleven patients with a metastatic endocrine tumor were selected before undergoing a right hepatectomy or a left hepatectomy passing along the median hepatic vein. Before the hepatectomy, patients underwent somatostatin receptor scintigraphy, computed tomography, magnetic resonance imaging, and ultrasonography (US). An intraoperative assessment (palpation and US) was also performed. Liver specimens were systematically cut into thin serial slices, 3- to 4-mm thick. A final histologic count of the total number of LM was obtained and compared with findings from each imaging technique.
Results: Compared with the final histologic count of LM, fewer than 50% of the LM were detected preoperatively. The accuracy was 24% for somatostatin receptor scintigraphy, 38% for computed tomography and US, and 49% for magnetic resonance imaging (the only imaging technique that detected half the number of LM). The size of the smallest LM was not greater than 2 mm in 54% of the patients.
Conclusion: Half the number of LM from neuroendocrine tumors are undetectable on preoperative imaging.
Similar articles
-
Clinical and imaging follow-up after exhaustive liver resection of endocrine metastases: a 15-year monocentric experience.Endocr Relat Cancer. 2009 Sep;16(3):977-90. doi: 10.1677/ERC-08-0247. Epub 2009 May 26. Endocr Relat Cancer. 2009. PMID: 19470616
-
Combined liver surgery and RFA for patients with gastroenteropancreatic endocrine tumors presenting with more than 15 metastases to the liver.Eur J Surg Oncol. 2009 Oct;35(10):1092-7. doi: 10.1016/j.ejso.2009.02.017. Epub 2009 May 21. Eur J Surg Oncol. 2009. PMID: 19464140
-
Detection of hepatic metastases from colorectal carcinoma: comparison of histopathologic features of anatomically resected liver with results of preoperative imaging.J Clin Gastroenterol. 2007 Sep;41(8):789-95. doi: 10.1097/01.mcg.0000225676.22218.08. J Clin Gastroenterol. 2007. PMID: 17700429
-
Treatment of neuroendocrine cancer metastatic to the liver: the role of ablative techniques.Cardiovasc Intervent Radiol. 2005 Jul-Aug;28(4):409-21. doi: 10.1007/s00270-004-4082-6. Cardiovasc Intervent Radiol. 2005. PMID: 16041556 Review.
-
Recommendations for management of patients with neuroendocrine liver metastases.Lancet Oncol. 2014 Jan;15(1):e8-21. doi: 10.1016/S1470-2045(13)70362-0. Lancet Oncol. 2014. PMID: 24384494 Review.
Cited by
-
ASO Practice Guidelines Series: Surgical Management of Gastrointestinal (Midgut) Neuroendocrine Neoplasms.Ann Surg Oncol. 2024 Mar;31(3):1704-1713. doi: 10.1245/s10434-023-14802-8. Epub 2024 Jan 2. Ann Surg Oncol. 2024. PMID: 38167813 Review.
-
Surgery as a Principle and Technical Consideration for Primary Tumor Resection of Small Bowel Neuroendocrine Tumors.Ann Surg Oncol. 2024 Feb;31(2):1125-1137. doi: 10.1245/s10434-023-14610-0. Epub 2023 Nov 25. Ann Surg Oncol. 2024. PMID: 38006527 Free PMC article. Review.
-
Defining MRI Superiority over CT for Colorectal and Neuroendocrine Liver Metastases.Cancers (Basel). 2023 Oct 23;15(20):5109. doi: 10.3390/cancers15205109. Cancers (Basel). 2023. PMID: 37894475 Free PMC article.
-
Long-Term Outcomes of Liver Transplantation for the Management of Neuroendocrine Neoplasms: A Systematic Review.J Pers Med. 2023 Sep 23;13(10):1428. doi: 10.3390/jpm13101428. J Pers Med. 2023. PMID: 37888039 Free PMC article. Review.
-
The Role of Liver Transplantation in the Treatment of Liver Metastases from Neuroendocrine Tumors.Curr Treat Options Oncol. 2023 Nov;24(11):1651-1665. doi: 10.1007/s11864-023-01124-w. Epub 2023 Oct 26. Curr Treat Options Oncol. 2023. PMID: 37882889 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical